In tumor-bearing mice, the combination of CSF3 and IL-6 cooperates to convert neutrophil precursors in the bone marrow into a pro-tumorigenic phenotype, while bone-marrow-derived neutrophils from mice lacking tumors have an anti-tumorigenic effect [53]. Here, CSF3 is linked to neoplasm.